Showing 281 - 300 results of 328 for search '"cognitive decline"', query time: 0.07s Refine Results
  1. 281

    Bidirectional Mendelian Randomization Analysis of the Association Between Mitochondrial Proteins and Neurodegenerative Diseases by Fangyuan Wang, Zhou Jing, Qingyi Wang, Minghe Li, Bingqi Lu, Ao Huo, Chenglin Zhao, Huanyu Zhou, Wulong Liang, Weihua Hu, Xudong Fu

    Published 2025-01-01
    “…ABSTRACT Background Neurodegenerative diseases involve progressive neuronal dysfunction and cognitive decline, posing substantial global challenges. …”
    Get full text
    Article
  2. 282

    Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles by Seyyed Sam Mehdi Hosseininasab, Rasoul Ebrahimi, Shirin Yaghoobpoor, Kiarash Kazemi, Yaser Khakpour, Ramtin Hajibeygi, Ashraf Mohamadkhani, Mobina Fathi, Kimia Vakili, Arian Tavasol, Zohreh Tutunchian, Tara Fazel, Mohammad Fathi, Mohammadreza Hajiesmaeili

    Published 2025-01-01
    “…., Toxoplasma gondii), have been linked to AD due to their ability to activate the immune system, induce inflammation and increase oxidative stress, thereby leading to cognitive decline and AD. In addition, microRNAs (miRNAs) might play a crucial role in the pathogenesis mechanisms of these pathogens since they are utilized to target various protein-coding genes, allowing for immune evasion, maintaining latency, and suppressing cellular signaling molecules. …”
    Get full text
    Article
  3. 283

    Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis by Simone Lorenzut, Ilaria Del Negro, Giada Pauletto, Lorenzo Verriello, Leopoldo Spadea, Carlo Salati, Mutali Musa, Caterina Gagliano, Marco Zeppieri

    Published 2025-01-01
    “…Demyelination interferes with the ability of the CNS to transmit signals, which can cause a variety of neurological symptoms, including impaired motor function, sensory deficiencies, and cognitive decline. Developing tailored therapeutics requires understanding the underlying processes guiding the course of the disease. …”
    Get full text
    Article
  4. 284
  5. 285

    Obesity-associated memory impairment and neuroinflammation precede widespread peripheral perturbations in aged rats by Michael J. Butler, Stephanie M. Muscat, Maria Elisa Caetano-Silva, Akriti Shrestha, Brigitte M. González Olmo, Sabrina E. Mackey-Alfonso, Nashali Massa, Bryan D. Alvarez, Jade A. Blackwell, Menaz N. Bettes, James W. DeMarsh, Robert H. McCusker, Jacob M. Allen, Ruth M. Barrientos

    Published 2025-01-01
    “…Abstract Background Obesity and metabolic syndrome are major public health concerns linked to cognitive decline with aging. Prior work from our lab has demonstrated that short-term high fat diet (HFD) rapidly impairs memory function via a neuroinflammatory mechanism. …”
    Get full text
    Article
  6. 286

    Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged mice by Nida Rasheed, Hafiza Khushbakht Hussain, Zohabia Rehman, Azka Sabir, Waseem Ashraf, Tanveer Ahmad, Faleh Alqahtani, Imran Imran

    Published 2025-01-01
    “…Aluminum chloride (AlCl3), a known neurotoxic and Alzheimerogenic metal disrupts redox homeostasis which plays a pivotal role in pathophysiology of neurodegenerative disorders, particularly cognitive decline. The current study was designed to unveil the long-term neuroprotective outcomes and efficacy of CoQ10 and curcumin low dose (100 mg/kg each) combination in 18-months old geriatric male Balb/c mice subjected to AlCl3-prompted memory derangements (200 mg/kg in water bottles) for 28 days. …”
    Get full text
    Article
  7. 287
  8. 288

    Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer’s Disease by Giuseppe Verdile, Kevin N. Keane, Vinicius F. Cruzat, Sandra Medic, Miheer Sabale, Joanne Rowles, Nadeeja Wijesekara, Ralph N. Martins, Paul E. Fraser, Philip Newsholme

    Published 2015-01-01
    “…Although epidemiological and biological evidence has highlighted an increased incidence of cognitive decline and AD in patients with T2DM, the common molecular basis of cell and tissue dysfunction is rapidly gaining recognition. …”
    Get full text
    Article
  9. 289

    Auditory agnosia for environmental sounds in Alzheimer’s disease: Effects on daily life by J.A. Coebergh, S. McDowell, T.C.A.M. van Woerkom, J.P. Koopman, J.L. Mulder, F.R.E. Smink, J.D. Blom, S.F.T.M. de Bruijn

    Published 2025-06-01
    “…On the basis of our findings we advise further longitudinal, multi-year studies of hearing screening and rehabilitation in Alzheimer’s disease, if possible starting during its prodromal stage, something supported by findings in a large trials suggesting that hearing interventions might be slowing cognitive decline in an older population at risk of this.…”
    Get full text
    Article
  10. 290

    Cerebellum abnormalities in vascular mild cognitive impairment with depression symptom patients: A multimodal magnetic resonance imaging study by Yirong Chen, Liling Chen, Liyu Hu, Jianjun Wang, Jinhuan Zhang, Hanqing Lyu, Jinping Xu, Jianxiang Chen, Haibo Yu

    Published 2025-02-01
    “…Background: Subcortical vascular mild cognitive impairment (svMCI) frequently occurs alongside depression symptoms, significantly affecting patients' quality of life. While cognitive decline and depression symptoms are linked to cerebellar changes, the specific relationship between these changes and cognitive status in svMCI patients with depression symptoms remains unclear. …”
    Get full text
    Article
  11. 291

    Lipid trajectories improve risk models for Alzheimer’s disease and mild cognitive impairment by Bruce A. Chase, Roberta Frigerio, Chad J. Yucus, Smita Patel, Demetrius Maraganore, Alan R. Sanders, Jubao Duan, Katerina Markopoulou

    Published 2025-01-01
    “…Inclusion of lipid-trajectory and VIM groups improved risk-model predictive performance independent of APOE and AD or lipid-level PRSs, providing important real-world perspectives on how longitudinal levels and variation of blood-lipid concentrations contribute to risk of cognitive decline.…”
    Get full text
    Article
  12. 292

    A study on the exploration of mild cognitive impairment in Parkinson’s disease based on decision-making cognitive computing by Shouqiang Huang, Kai Li, Kai Li, Chen Wang, Jiakang Liu, Shuwu Li, Yuting Tu, Bo Wang, Huangqin Feng, Qin Yu, Hongzhou Lin, Yuzhe Xu, Jinghang Wu, Ting Zhang, Tong Chen

    Published 2025-01-01
    “…Therefore, this study explored deficits in decision-making cognitive function in PD-MCI population, and mined novel digital biomarkers for recognizing early cognitive decline in PD-MCI through an independently designed maze decision-making digital assessment paradigm. …”
    Get full text
    Article
  13. 293

    Hormone replacement therapy, menopausal age and lifestyle variables are associated with better cognitive performance at follow-up but not cognition over time in older-adult women i... by Tamlyn J. Watermeyer, Tamlyn J. Watermeyer, Sarah Gregory, Sarah Gregory, Emmi Leetham, Chinedu T. Udeh-Momoh, Chinedu T. Udeh-Momoh, Chinedu T. Udeh-Momoh, Chinedu T. Udeh-Momoh, Chinedu T. Udeh-Momoh, Graciela Muniz-Terrera, Graciela Muniz-Terrera

    Published 2025-01-01
    “…Two regression models were employed: one analyzing cognitive performance at follow-up and another examining changes in cognitive scores over time.ResultsResults indicate that while age, education, HRT use, age at menopause, alcohol consumption, and diet were associated with cognitive function at a single later time point, only age remained a significant predictor when modeling cognition over time.DiscussionThese findings suggest that while HRT, menopausal age and lifestyle factors may support cognitive stability, they do not necessarily predict cognitive decline in post-menopausal older women. A major limitation of the current work is the lack of detail regarding HRT use, such as formulation, timing and duration; caveats that future studies should address. …”
    Get full text
    Article
  14. 294

    Systematic analysis and prediction of the burden of Alzheimer’s disease and other dementias caused by hyperglycemia by Dongying He, Dongying He, Manting Liu, Yujin Tang, Xiaona Tian, Lisi Zhou, Yizhen Chen, Xiaoxia Liu, Xiaoxia Liu

    Published 2025-02-01
    “…Emerging evidence has identified high fasting plasma glucose (HFPG) as a major modifiable risk factor for ADOD, linking impaired glucose metabolism to cognitive decline and neurodegeneration. Despite this association, the comprehensive impact of HFPG on the global burden of ADOD has not been fully elucidated. …”
    Get full text
    Article
  15. 295

    Optimizing electrode configurations for EEG mild cognitive impairment detection by Yi Jiang, Xin Zhang, Zhiwei Guo, Xiaobo Zhou, Jiayuan He, Ning Jiang

    Published 2025-01-01
    “…The abnormal brain rhythm characteristics of the frontal, parietal, and occipital lobes in the memory encoding stage of MCI provide a new perspective for MCI-WM impairment, which has the potential to be a novel biomarker for the early detection of pathological age-related cognitive decline. Further, a potential four-electrode configuration may be used for a novel detecting and monitoring EEG system of MCI in non-clinical settings.…”
    Get full text
    Article
  16. 296

    Effect of Simple Reaction Speed Training on Executive Function of the Elderly with Mild Cognitive Impairment by Hong ZHANG, Xiaofei WEI, Congyong LIU, Kaili QIAN, Chun LI, Rang LI, Yuan JIANG

    Published 2021-04-01
    “…Moreover, the serum brain-derived neurotrophic factor in the blood before and after intervention was detected by using enzyme linked immunosorbent assay (ELISA), respectively.Results:Compared with before intervention, the scores of conversion, working memory, planning, task monitoring, MI, total standard scores, TMT-B and interference in the observation group after intervention for three months were significantly lower, KST, TJT, ZMT, total standard scores and level of serum BDNF of the observation group after intervention were significantly higher (<italic>P</italic>&lt; 0.05); compared with the control group, the scores of conversion, task initiation, working memory, planning, BRI, MI, total standard scores, TMT-B and interferences of the observation group were significantly lower, and RSCT, KST, TJT, ZMT, total standard scores and level of serum brain-derived neurotrophic factor (BDNF) of the observation group were significantly high (<italic>P</italic>&lt; 0.05).Conclusion:Simple reaction speed training can improve the executive function, brain nerve function, and effectively delay cognitive decline of elderly with MCI.…”
    Get full text
    Article
  17. 297

    Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease by G. Pšemeneckienė, K. Petrikonis, D. Rastenytė

    Published 2019-09-01
    “…The study included 110 patients with sporadic AD and 115 age-and-gender-matched healthy controls (HC) without cognitive decline (Lithuanian population). Genotyping of IL1A -889C>T (rs1800587) and IL6 -174G>C (rs1800795, Intron type) was performed using real-time PCR (RT-PCR). …”
    Get full text
    Article
  18. 298
  19. 299

    Omega-3 Fatty Acids: Key Players in Cognitive Function and Brain Health by Wiktoria Wesołowska, Emilia Bachoń, Michalina Doligalska, Aleksandra Stremel, Agnieszka Leszyńska, Julia Linke, Zuzanna Bałoniak, Dominika Kozłowska, Julia Bałoniak, Weronika Tuszyńska

    Published 2025-01-01
    “…Modern diets, often lacking in omega-3, highlight their importance in combating cognitive decline, neurodegenerative diseases, and mental disorders. …”
    Get full text
    Article
  20. 300

    The role of the KIBRA and APOE genes in developing spatial abilities in humans by A. V. Kazantseva, R. F. Enikeeva, Yu. D. Davydova, R. N. Mustafin, Z. R. Takhirova, S. B. Malykh, M. M. Lobaskova, T. N. Tikhomirova, E. K. Khusnutdinova

    Published 2022-01-01
    “…Considering a significant role of genetic and environmental components in cognitive functioning, the present study aimed to estimate the main effect of NGF (rs6330), NRXN1 (rs1045881, rs4971648), KIBRA (rs17070145), NRG1 (rs6994992), BDNF (rs6265), GRIN2B (rs3764030), APOE (rs7412, rs429358), and SNAP25 (rs363050) gene polymorphisms and to assess the effect of gene-environment interactions on individual differences in spatial ability in individuals without cognitive decline aged 18–25 years (N = 1011, 80 % women). …”
    Get full text
    Article